BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05845814-completion@plaintrial.com
DTSTAMP:20261028T135936Z
DTSTART;VALUE=DATE:20270531
SUMMARY:A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Ved
 otin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial C
 arcinoma (mUC) (MK-3475-04B/KEYMAKER-U04) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT05845814
URL:https://plaintrial.com/trial/NCT05845814
END:VEVENT
END:VCALENDAR